Long-Term Care, Home Health & Hospice

Print PDF

Nursing Home Compare Updates Highlight Differences for Anti-Psychotic Use Between MDS 3.0, CASPER

Posted on August 3, 2012 in Long-Term Care, Home Health & Hospice

Written by: Bufford, David W.

As part of the Centers for Medicare & Medicaid Services (CMS) ongoing program to reduce the rate of anti-psychotic use in nursing facilities, the recent changes to the Nursing Home Compare (NHC) website included reports of the usage rates of anti-psychotics in a facility’s score.  However, there is a discrepancy between the methodologies utilized by the CMS Certification and Survey Provider Enhanced Reporting (CASPER)  and MDS 3.0 in calculating anti-psychotic use within a facility.  This has lead to conflicting figures between the NHC website, which uses the MDS 3.0 measure, and that which is found in the CASPER Reports for the same facility.  

To address this disparity, CMS has offered an interim solution that addresses the comparability of the two figures until the CASPER measure can be replaced with a measure that matches the MDS 3.0 methodology used for the NHC website.

Should you have any questions, please contact:
Todd Selby at 317.977.1440 or;
Brian Jent at 317.977.1402 or; or
David Bufford at 502.568.9368 or,
or your regular Hall Render attorney.